Encompass Health Corporation (EHC) Insider Trading Activity

NYSE$115.07+1.22 (1.07%)
Market Cap
$11.47B
Sector
Healthcare
Industry
Medical—Care Facilities
Rank in Sector
525 of 832
Rank in Industry
27 of 38

EHC Insider Trading Activity

EHC Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$21,673,204
6
100

Related Transactions

Tuer Patrick WilliamEVP, Chief Operating Officer
0
$0
1
$126,062
$-126,062
Price Andrew LChief Accounting Officer
0
$0
1
$495,578
$-495,578
Charbonneau Elissa JoyChief Medical Officer
0
$0
1
$498,974
$-498,974
Darby John PatrickEVP, Gen Counsel & Secretary
0
$0
1
$1.15M
$-1.15M
COLTHARP DOUGLAS EEVP & Chief Financial Officer
0
$0
1
$5.02M
$-5.02M
Tarr Mark JPresident & CEO
0
$0
1
$14.39M
$-14.39M

About Encompass Health Corporation

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of June 1, 2022, it operated 149 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.

Insider Activity of Encompass Health Corporation

Over the last 12 months, insiders at Encompass Health Corporation have bought $0 and sold $21.67M worth of Encompass Health Corporation stock.

On average, over the past 5 years, insiders at Encompass Health Corporation have bought $187,033 and sold $7.24M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 2,000 shares for transaction amount of $167,460 was made by CARMICHAEL GREG D (director) on 2024‑05‑03.

List of Insider Buy and Sell Transactions, Encompass Health Corporation

2025-08-27SaleTuer Patrick WilliamEVP, Chief Operating Officer
1,020
0.001%
$123.59
$126,062
+0.73%
2025-05-20SaleTarr Mark JPresident & CEO
118,384
0.1173%
$121.53
$14.39M
-0.37%
2025-05-06SaleCharbonneau Elissa JoyChief Medical Officer
4,279
0.0042%
$116.61
$498,974
+3.33%
2025-04-29SaleDarby John PatrickEVP, Gen Counsel & Secretary
10,000
0.0098%
$114.79
$1.15M
+4.28%
2025-04-29SaleCOLTHARP DOUGLAS EEVP & Chief Financial Officer
43,575
0.0429%
$115.15
$5.02M
+4.28%
2025-02-13SalePrice Andrew LChief Accounting Officer
5,042
0.005%
$98.29
$495,578
+19.01%
2024-08-13SaleCOLTHARP DOUGLAS EEVP & Chief Financial Officer
12,260
0.0121%
$86.34
$1.06M
+15.44%
2024-05-24SaleCharbonneau Elissa JoyChief Medical Officer
10,000
0.01%
$85.02
$850,200
+13.99%
2024-05-06SaleDarby John PatrickEVP, Gen Counsel & Secretary
14,543
0.0143%
$83.94
$1.22M
+12.42%
2024-05-03PurchaseCARMICHAEL GREG Ddirector
2,000
0.002%
$83.73
$167,460
+14.07%
2024-04-30SaleTarr Mark JPresident & CEO
44,976
0.0449%
$83.27
$3.75M
+13.68%
2023-11-13SaleCOLTHARP DOUGLAS EEVP & Chief Financial Officer
11,215
0.0112%
$63.39
$710,919
+33.82%
2023-08-17SaleCharbonneau Elissa JoyChief Medical Officer
8,294
0.0083%
$69.58
$577,097
+7.13%
2023-08-16SaleTarr Mark JPresident & CEO
25,330
0.0254%
$71.06
$1.8M
+4.73%
2023-02-10SaleCOLTHARP DOUGLAS EEVP & Chief Financial Officer
17,895
0.0178%
$60.78
$1.09M
+6.87%
2022-10-31PurchaseCARMICHAEL GREG Ddirector
1,830
0.0019%
$54.67
$100,046
+14.50%
2022-08-17SaleTarr Mark JPresident & CEO
20,449
0.0207%
$53.25
$1.09M
+13.50%
2022-05-05PurchaseO'Connor Kevin J.
1,000
0.001%
$66.48
$66,480
-0.25%
2021-12-02PurchaseWilliams Terrancedirector
708
0.0007%
$56.61
$40,080
+11.14%
2021-03-08SalePrice Andrew LChief Accounting Officer
17,178
0.0174%
$81.40
$1.4M
-3.91%
Total: 95
*Gray background shows transactions not older than one year

Insider Historical Profitability

12.28%
Tarr Mark JPresident & CEO
527070
0.5233%
$60.01M214
+10.57%
Darby John PatrickEVP, Gen Counsel & Secretary
79710
0.0791%
$9.07M02
Price Andrew LChief Accounting Officer
69164
0.0687%
$7.87M05
COLTHARP DOUGLAS EEVP & Chief Financial Officer
60335
0.0599%
$6.87M15
+14.47%
Tuer Patrick WilliamEVP, Chief Operating Officer
18846
0.0187%
$2.15M01
Charbonneau Elissa JoyChief Medical Officer
11958
0.0119%
$1.36M14
+19.01%
GRINNEY JAYPres & Chief Executive Officer
1118629
1.1106%
$127.36M48
+10.79%
Anthony April Kaye BullockCEO & President, Home Health
191740
0.1904%
$21.83M20
+11.4%
Workman John LChief Financial Officer
96705
0.096%
$11.01M40
<0.0001%
STRONG GEORGE Hdirector
89217
0.0886%
$10.16M10
+3.95%
CHIDSEY JOHNdirector
88412
0.0878%
$10.07M10
+16.9%
Fay EdmundSr. Vice Pres. and Treasurer
74975
0.0744%
$8.54M12
+11.94%
HANSON JON Fdirector
74415
0.0739%
$8.47M11
+0.67%
HIGDON LEO I JRdirector
73738
0.0732%
$8.4M30
+9.57%
CURL YVONNE Mdirector
71555
0.071%
$8.15M20
+19.55%
CORRELL DONALD Ldirector
70568
0.0701%
$8.03M11
+25.65%
Whittington John PGen. Counsel & Secretary
52857
0.0525%
$6.02M30
+8.25%
BLECHSCHMIDT EDWARD Adirector
52749
0.0524%
$6.01M70
+16.16%
Jacobsmeyer Barbara AnnPresident, Inpatient Hospitals
44761
0.0444%
$5.1M03
Levy Cheryl B.Chief Human Resources Officer
39567
0.0393%
$4.5M04
SHAW L EDWARD JRdirector
26653
0.0265%
$3.03M20
<0.0001%
Clohan Dexanne BSVP & Chief Medical Officer
20500
0.0204%
$2.33M10
+86.34%
CARMICHAEL GREG Ddirector
17050
0.0169%
$1.94M20
+14.29%
MAUPIN JOHN E JR D D Sdirector
15898
0.0158%
$1.81M10
+21.55%
ELSON CHARLES Mdirector
14557
0.0145%
$1.66M10
+0.67%
HERMAN JOAN Edirector
13590
0.0135%
$1.55M10
+13.74%
KATZ LESLYE Gdirector
6118
0.0061%
$696,534.3010
+17.46%
Williams Terrancedirector
5258
0.0052%
$598,623.3010
+11.14%
O'Connor Kevin J.
3436
0.0034%
$391,188.6010
<0.0001%
*Gray background shows insiders who have made transactions during last year

EHC Institutional Investors: Active Positions

Increased Positions325+54.81%8M+7.96%
Decreased Positions259-43.68%9M-9.52%
New Positions102New2MNew
Sold Out Positions38Sold Out503,163Sold Out
Total Postitions659+11.13%95M-1.57%

EHC Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$1.18M10.28%10.38M-30,586-0.29%2025-06-30
Blackrock, Inc.$1.12M9.77%9.87M-492,696-4.75%2025-06-30
Invesco Ltd.$642,014.005.58%5.64M-179,659-3.09%2025-06-30
Wellington Management Group Llp$401,386.003.49%3.53M-93,040-2.57%2025-06-30
State Street Corp$353,591.003.08%3.11M-70,226-2.21%2025-06-30
T. Rowe Price Investment Management, Inc.$247,709.002.15%2.18M+94,830+4.56%2025-06-30
Alliancebernstein L.P.$232,176.002.02%2.04M+129,276+6.77%2025-06-30
Fuller & Thaler Asset Management, Inc.$207,640.001.81%1.82M+282,323+18.32%2025-06-30
Geode Capital Management, Llc$201,918.001.76%1.77M+8,765+0.5%2025-06-30
Fmr Llc$193,428.001.68%1.7M-227,926-11.83%2025-06-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.